Try our Advanced Search for more refined results
Intellectual Property
-
February 09, 2026
Trump Names 2 Picks For ITC Commissioner Spots
President Donald Trump has nominated a counsel for the U.S. House of Representatives' intellectual property subcommittee and an assistant U.S. trade representative to be members of the U.S. International Trade Commission.
-
February 09, 2026
Paramount, Effects Co. Sue Each Other Over 'Scream' Mask
A special effects business and the entertainment companies behind the upcoming "Scream 7" film have filed lawsuits against one another in California federal court over the slasher movie franchise's iconic "Ghostface" mask.
-
February 09, 2026
Judge OKs Sanctions In Valve Fight, Warns More May Come
A Seattle federal judge on Monday granted video game maker Valve Corp.'s request to sanction a rival litigant over discovery violations just ahead of a trial on the company's allegations of bad faith patent infringement claims, and threatened to issue more over a legal brief that contained fake quotes and fabricated citations generated by artificial intelligence.
-
February 09, 2026
Fed. Circ. Uses Alice To Scrap $2.5M Netflix Patent Verdict
The Federal Circuit on Monday threw out a California jury's $2.5 million verdict against Netflix for infringing a GoTV Streaming LLC patent on wireless content delivery, agreeing with the streaming giant that the patent and two others are invalid because they cover only abstract ideas.
-
February 09, 2026
Kurin Fights $1.6M IP Verdict As Rival Seeks More Damages
Kurin has urged a Delaware federal judge to overturn Magnolia Medical's $1.6 million patent verdict or order a new trial, while Magnolia Medical has asked the court to bar Kurin from selling allegedly infringing "Jet" blood-culture collection products and award it supplemental damages on Kurin's sales, plus ongoing royalties and interest.
-
February 09, 2026
8th Circ. Lets Stand Minn. Law Banning Election Deepfakes
The Eighth Circuit on Monday declined to block Minnesota's law criminalizing deepfakes that are designed to influence elections, holding in a published opinion that a state legislator waited too long to seek emergency relief and that a political commentator who also challenged the statute did not have standing.
-
February 09, 2026
Tribal Corp. Says Colorado Consultant Misused Trade Secrets
An Alaskan tribal corporation is suing a Colorado consultant and her firm, alleging that she used its trade secret information to attempt to lure government contracting clients away by publicly advertising the data and claiming it as her own.
-
February 09, 2026
USPTO Targets Double-Dipping In Anon. Ex Parte Challenges
The U.S. Patent and Trademark Office is now requiring those who anonymously petition it to reexamine a patent's validity to certify that they haven't already challenged it at the Patent Trial and Appeal Board.
-
February 09, 2026
Videographer Fights 4th Circ.'s Choice To Shipwreck IP Suit
A videographer and his production company urged the full Fourth Circuit to let him revive his copyright infringement lawsuit over footage of Blackbeard's shipwreck, arguing Monday that a panel's recent opinion to end the case laid new and overly broad pathways for pendent jurisdiction.
-
February 09, 2026
Fed. Circ. Won't Reboot Startup's Patent Suit Against Shopify
The Federal Circuit on Monday declined to breathe new life into a case from a defunct digital media startup alleging that Shopify was infringing its patents by using ideas disclosed during talks about a potential partnership.
-
February 09, 2026
Fed. Circ. Sends Blood Pump Patent Fight Back To Mass.
The Federal Circuit on Monday reversed a lower court's ruling that Abiomed Inc. hasn't infringed five patents on blood pump systems and methods, while backing the part of the decision that cleared the medical device technology company of allegations it infringed a different patent.
-
February 09, 2026
'Baby Shark' Ruling Doesn't Stop Google Anti-Phishing Fight
A Manhattan federal judge granted injunctive relief Monday to Google in its effort to combat an alleged China-based phishing enterprise, holding that faraway defendants were properly served electronically despite an appellate ruling mandating mail service in a "Baby Shark" infringement case.
-
February 09, 2026
Novo Nordisk Sues Hims & Hers Over Knockoff GLP-1
Novo Nordisk AS followed through on Monday in Delaware federal court on a plan it announced last week to sue telehealth company Hims & Hers Health Inc. over its marketing of what Novo Nordisk calls a knockoff version of its GLP-1 medications.
-
February 09, 2026
Intellectual Property Group Of The Year: Susman Godfrey
Susman Godfrey LLP attorneys in the past year achieved some of the most closely watched victories in copyright, privacy and life sciences, including a record-setting copyright class settlement over books Anthropic obtained to train its flagship artificial intelligence model, earning the firm a spot among the 2025 Law360 Intellectual Property Groups of the Year.
-
February 09, 2026
High Court Asked To Take Up Malpractice Case Against Akin
A former Cornell University graduate student wants the U.S. Supreme Court to review the dismissal of his suit accusing Akin Gump Strauss Hauer & Feld LLP attorneys of manipulating patent litigation to steal his DNA sequencing intellectual property.
-
February 06, 2026
Takeda Can't Ax Most Of Heartburn Drug Pay-For-Delay Suit
Takeda Pharmaceutical Co. and TWi Pharmaceuticals must face most of a proposed antitrust class action accusing them of delaying the release of the generic version of Takeda's heartburn medication Dexilant, causing Walgreens, Kroger and other retailers to pay more for the brand-name drug, a California federal judge ruled Friday.
-
February 06, 2026
OpenAI Can Keep Atty Comms Secret After All, Judge Says
A New York federal judge Friday set aside a magistrate judge's order requiring OpenAI's in-house attorneys to share their internal communications regarding deleted training datasets with authors suing over alleged copyright infringement, holding that the conclusions underlying that decision were "clearly erroneous or contrary to law."
-
February 06, 2026
HHS Refers Hims & Hers To DOJ Amid Compound Drug Fight
U.S. Department of Health and Human Services general counsel Mike Stuart announced Friday that his office referred Hims & Hers Health Inc. to the U.S. Department of Justice for investigation, a day after Novo Nordisk A/S threatened litigation over what it called the telehealth company's "knockoff" version of its popular weight loss drug Wegovy.
-
February 06, 2026
Squires Rules Inconsistent Claim Constructions Doom 3 IPRs
U.S. Patent and Trademark Office Director John Squires has undone three decisions by the Patent Trial and Appeal Board instituting inter partes reviews, finding that the patent challengers made conflicting claim construction arguments in the reviews and in court.
-
February 06, 2026
'Very Bizarre': Trump's Funding Freeze Appeal Vexes DC Circ.
D.C. Circuit judges struggled Friday with whether to unblock a federal funding freeze carrying multitrillion-dollar implications, as a Trump administration lawyer disclaimed interest in a vast spending halt but also dodged opportunities to rule it out unequivocally.
-
February 06, 2026
NJ Judge Tosses Pacira Investor Suit Over Patent Loss
A New Jersey federal judge on Friday threw out an investor lawsuit against Pacira BioSciences Inc. after a court invalidated a patent for its key pain management drug, ruling that the pharmaceutical company was not required to disclose litigation setbacks it encountered before the final ruling.
-
February 06, 2026
Tesla, X Accused Of Infringing Voice Assistance Tech Patent
Tesla Inc., X Corp., and an Indian technology company were all hit with patent infringement lawsuits in Texas federal court over their technology that uses voice assistance.
-
February 06, 2026
Skating, Twirling And Juggling IP Risk At The Winter Olympics
Snowboarders, figure skaters, curlers and other competitive athletes have been training for years to be ready for the unexpected at the Winter Olympics, but intellectual property issues arising from taking part in the global sporting event are probably not high on their priority list.
-
February 06, 2026
PTAB Tosses 2nd Patent On Cologuard Colon Cancer Test
The Patent Trial and Appeal Board has found that Geneoscopy had shown that all the claims it challenged in a patent on Exact Sciences' colon cancer test Cologuard are invalid as obvious, months after the PTAB invalidated claims in a similar patent.
-
February 06, 2026
'Cardiac Pack' Wants NC Justices To Revive NIL Suit
A group of former student-athletes from the early 1980s is urging North Carolina's highest court to revive their name, image and likeness lawsuit against the NCAA, arguing the organization's use of gameplay footage to advertise March Madness is a continuing harm.
Expert Analysis
-
Attys Beware: Generative AI Can Also Hallucinate Metadata
In addition to the well-known problem of AI-generated hallucinations in legal documents, AI tools can also hallucinate metadata — threatening the integrity of discovery, the reliability of evidence and the ability to definitively identify the provenance of electronic documents, say attorneys at Law & Forensics.
-
Lessons From Fed. Circ. On Expert Testimony In Patent Cases
Several recent decisions from the Federal Circuit are notable for their treatment of expert testimony, with relevance to the three pillars of every patent case — infringement, invalidity and damages — and offer lessons on ensuring that expert testimony is both admissible and sufficient to support the jury's verdict, say attorneys at Honigman.
-
When Atty Ethics Violations Give Rise To Causes Of Action
Though the Model Rules of Professional Conduct make clear that a violation of the rules does not automatically create a cause of action, attorneys should beware of a few scenarios in which they could face lawsuits for ethical lapses, says Brian Faughnan at Faughnan Law.
-
TikTok Divestiture Deal Revolves Around IP Considerations
The divestiture deal between the U.S. and China to resolve a security dispute over TikTok's U.S. operations is seen as a diplomatic breakthrough, but its success hinges on the treatment of intellectual property and may set a precedent in the global contest over digital sovereignty and IP control, say attorneys at Brownstein Hyatt.
-
Trending At The PTAB: A Potential Barrier To Serial Challenges
New rules proposed by the U.S. Patent and Trademark Office may appear similar to previous rules at first glance, but are actually much broader in how they would limit petitioners' ability to challenge a patent more than once, say attorneys at Finnegan.
-
Fed. Circ. In September: The Printed Matter Doctrine Expands
The Federal Circuit’s recent decision in Bayer v. Mylan represents an extension of the doctrine that adding new words to an existing product or method will not support patentability unless there is a functional relationship, bringing new considerations for both patent holders and challengers, say attorneys at Knobbe Martens.
-
10 Quick Tips To Elevate Your Evidence Presentation At Trial
A strong piece of evidence, whether in the form of testimony or exhibit, is wasted if not presented effectively, so attorneys must prepare with precision to help fact-finders both retain the information and internalize its significance, says Allison Rocker at Baker McKenzie.
-
Series
Practicing Stoicism Makes Me A Better Lawyer
Practicing Stoicism, by applying reason to ignore my emotions and govern my decisions, has enabled me to approach challenging situations in a structured way, ultimately providing advice singularly devoted to a client's interest, says John Baranello at Moses & Singer.
-
Broader Eligibility For AI-Related Patents May Be Coming
A series of recent developments from the U.S. Patent and Trademark Office appears to signal that claims involving improvement in the operation of a machine learning model are now more likely to be considered patent-eligible, and that patent examiners may focus on questions of novelty and nonobviousness and less so on subject matter eligibility, say attorneys at Kilpatrick.
-
Series
The Biz Court Digest: Texas, One Year In
A year after the Texas Business Court's first decision, it's clear that Texas didn't just copy Delaware and instead built something uniquely its own, combining specialization with constitutional accountability and creating a model that looks forward without losing touch with the state's democratic and statutory roots, says Chris Bankler at Jackson Walker.
-
Series
Law School's Missed Lessons: Educating Your Community
Nearly two decades prosecuting scammers and elder fraud taught me that proactively educating the public about the risks they face and the rights they possess is essential to building trust within our communities, empowering otherwise vulnerable citizens and preventing wrongdoers from gaining a foothold, says Roger Handberg at GrayRobinson.
-
Adapting To USPTO's Reduction Of Examiner Interview Time
Reported changes to the U.S. Patent and Trademark Office's examiner performance appraisal plan will likely make interviews scarcer throughout the application process, potentially influencing patent allowance rates and increasing the importance of approaching each interview with a clear agenda and well-defined goals, say attorneys at Polsinelli.
-
What To Know About Interim Licenses In Global FRAND Cases
Recent U.K. court decisions have shaped a framework for interim licenses in global standard-essential patent disputes, under which parties can benefit from operating on temporary terms while a court determines the final fair, reasonable and nondiscriminatory terms — but the future of this developing remedy is in doubt, say attorneys at Fish & Richardson.
-
5 Crisis Lawyering Skills For An Age Of Uncertainty
As attorneys increasingly face unprecedented and pervasive situations — from prosecutions of law enforcement officials to executive orders targeting law firms — they must develop several essential competencies of effective crisis lawyering, says Ray Brescia at Albany Law School.
-
Anticipating FTC's Shift On Unfair Competition Enforcement
As the Federal Trade Commission signals that it will continue to challenge unfair or deceptive acts and practices under Section 5 of the FTC Act, but with higher evidentiary standards, attorneys counseling healthcare, technology, energy or pharmaceuticals clients should note several practice tips, says Thomas Stratmann at George Mason University.